Previous Close | 2.1500 |
Open | 2.0700 |
Bid | 0.0000 x 1000 |
Ask | 0.0000 x 1400 |
Day's Range | 2.0500 - 2.2388 |
52 Week Range | 1.2300 - 6.5000 |
Volume | |
Avg. Volume | 82,938 |
Market Cap | 20.782M |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | -1.7570 |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Subscribe to Yahoo Finance Plus to view Fair Value for TIVC
NEW YORK, June 21, 2022 (GLOBE NEWSWIRE) -- Diamond Equity Research, a leading equity research firm with a focus on small capitalization public companies has initiated coverage of Tivic Health Systems, Inc. (NASDAQ: TIVC). The in-depth 18-page initiation report includes detailed information on the Tivic Health System’s business model, services, industry, valuation, management, and risks. The full research report is available here. Highlights from the report include: Platform Model Provides Scala
SAN FRANCISCO, June 16, 2022--Tivic Health® Systems, Inc. (Nasdaq: TIVC), a commercial-phase health technology company that develops and commercializes bioelectronic medicine, today announced that for the second consecutive year ClearUP® Sinus Pain Relief has received Global Health & Pharma’s 2022 award for Most Innovative Sinus Relief Solution. ClearUP is a small handheld device that is FDA-cleared, CE marked, and clinically proven to provide relief from sinus pain and congestion from allergies
SAN FRANCISCO, June 13, 2022--Tivic Health® Systems, Inc. (Nasdaq: TIVC), a commercial-phase health technology company that develops and commercializes bioelectronic medicine, today announced the Annual General Meeting of Shareholders will be held on Tuesday, June 14, 2022, at 10:00 a.m., Pacific Daylight Time. The Company has adopted a virtual format for our Annual Meeting to provide a healthy, consistent, and convenient experience for all stockholders regardless of location.